The Zacks Analyst Blog Highlights AbbVie, Lilly, Sanofi, Merck and J&J
Zacks via Yahoo Finance· 2 hours agoThe FDA approved Lilly’s diabetes drug, Jardiance (empagliflozin), for expanded use in chronic...
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation
Motley Fool· 11 hours agoLast year, the company won innovation awards for four of its products, including its continuous...
Smart Diabetes Management Market Size, Share, Trends, Demand, Growth Forecast, Segmentation and...
Digital Journal· 5 days agoSmart Diabetes Management Market report offers better solution for refining the business strategies to thrive in this competitive market place. A number of trustworthy sources ...
Analysis | FDA moves to regulate laboratory medical tests
Washington Post· 2 hours agoHappy Monday and welcome to The Health 202, where we had expected to be writing today about the...
ALR Technologies Announces Patent Grant for Predictive A1C and Successful Results from Singapore...
Hawaii News Now· 4 days agoALR Technologies SG Ltd. ("ALRT" or the "Company") (OTCQB: ALRTF), a diabetes management company, announces the patent application titled Method and System of Monitoring a ...
How Ozempic could help combat the next pandemic
Newsweek· 1 day agoOzempic, the new weight-loss drug, has outperformed the GDP of Denmark—where it is produced—and is already being trialled by the U.K.'s National Health...
Ketonemia: Definition, causes, and when to seek help
Medical News Today· 3 days ago“Ketonemia” is a term that describes an unusually high amount of ketone bodies in the blood. This is due to a process called ketosis, during which the body burns fat for energy instead of glucose ...
mHealth Solutions Market Revenue Share Study Analysis Report
Digital Journal· 5 days agoInsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global mHealth Solutions Market Size, Share & Trends Analysis Report By Product Type (Patient Management ...
F.D.A. Moves to Regulate Lab Tests That It Says Put Patients ‘at Risk’
New York Times· 3 days agoGenetic testing that reveals potential cancer risks or other maladies with no regulatory oversight...
The 2023 Assembly Show to Feature New Product of The Year Awards; All Attendees Are Invited to Judge...
Digital Journal· 6 days agoInvestors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! Samsara Inc. (IOT) Investigation...
Yahoo Web Search
Trending Now
